We use some essential cookies to make this website work.
We’d like to set additional cookies to understand how you use GOV.UK, remember your settings and improve government services.
We also use cookies set by other sites to help us deliver content from their services.
You have accepted additional cookies. You can change your cookie settings at any time.
You have rejected additional cookies. You can change your cookie settings at any time.
Departments, agencies and public bodies
News stories, speeches, letters and notices
Detailed guidance, regulations and rules
Reports, analysis and official statistics
Consultations and strategy
Data, Freedom of Information releases and corporate reports
Placing a veterinary medicine on the market, including non-medicinal products, how to obtain advice and report non-compliance.
Explainer on the rules for advertising products used in, on or near animals that are not licensed veterinary medicines.
How the MHRA makes decisions on what is a medicinal product (borderline products).
You must include the appropriate legal basis for your application when you apply to MHRA for a marketing authorisation.
How to apply for a clinical trial (prior to 28 April 2026) including eligibility, phases, model IMPDs, costs and how to make changes to your application.
List of substances recognised as medicinal by function.
B. Braun Melsungen AG has notified the MHRA that errors have been identified in the Patient Information Leaflet (PIL) included in some batches of Meropenem 1000 mg powder and solvent for solution for infusion.
How the MHRA treats traditional herbal medicines and homeopathic medicines.
You must get permission to export certain drugs and medicines.
Guidance on using non-investigational medicinal products in a clinical trial.
Do not include personal or financial information like your National Insurance number or credit card details.
To help us improve GOV.UK, we’d like to know more about your visit today. Please fill in this survey (opens in a new tab and requires JavaScript).